Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.

Ozempic is a popular prescription medication for type 2 diabetes and weight loss. But before you start taking Ozempic, it's ...

Demi Moore, Nicole Kidman and Mindy Kaling are among the stars who stepped out with slimmed-down figures during awards season, a trend that one expert says could be due to a "combination of factors." ...

Many people who have tried to lose weight by cutting calories are familiar with this frustrating reality: At some point, the ...

Kourtney Kardashian's ex, Scott Disick, admitted to using Mounjaro on a recent episode of The Kardashians which hit our ...

While GLP-1 drugs are currently available in the market, the Food and Drug Administration (FDA) had declared a shortage of semaglutide supply since 2022 after its popularity skyrocketed following news ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

In recent years, the landscape of diabetes and weight management has been significantly altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists. These medications, initially developed ...

You've probably heard about the relatively new weight loss medications and the results some people have seen with them and you may have wondered if they could help you.

Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...